477 related articles for article (PubMed ID: 26335953)
1. Cystic fibrosis lung microbiome: opportunities to reconsider management of airway infection.
Caverly LJ; Zhao J; LiPuma JJ
Pediatr Pulmonol; 2015 Oct; 50 Suppl 40():S31-8. PubMed ID: 26335953
[TBL] [Abstract][Full Text] [Related]
2. Cystic fibrosis respiratory microbiota: unraveling complexity to inform clinical practice.
Caverly LJ; LiPuma JJ
Expert Rev Respir Med; 2018 Oct; 12(10):857-865. PubMed ID: 30118374
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections.
Chmiel JF; Aksamit TR; Chotirmall SH; Dasenbrook EC; Elborn JS; LiPuma JJ; Ranganathan SC; Waters VJ; Ratjen FA
Ann Am Thorac Soc; 2014 Sep; 11(7):1120-9. PubMed ID: 25102221
[TBL] [Abstract][Full Text] [Related]
4. The cystic fibrosis airway microbiome.
Rabin HR; Surette MG
Curr Opin Pulm Med; 2012 Nov; 18(6):622-7. PubMed ID: 22965275
[TBL] [Abstract][Full Text] [Related]
5. The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis.
Frayman KB; Armstrong DS; Carzino R; Ferkol TW; Grimwood K; Storch GA; Teo SM; Wylie KM; Ranganathan SC
Thorax; 2017 Dec; 72(12):1104-1112. PubMed ID: 28280235
[TBL] [Abstract][Full Text] [Related]
6. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details.
Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C
Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782
[TBL] [Abstract][Full Text] [Related]
7. The airway microbiome in cystic fibrosis and implications for treatment.
Zemanick ET; Sagel SD; Harris JK
Curr Opin Pediatr; 2011 Jun; 23(3):319-24. PubMed ID: 21494150
[TBL] [Abstract][Full Text] [Related]
8. Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens.
Vandeplassche E; Tavernier S; Coenye T; Crabbé A
Eur Respir Rev; 2019 Jun; 28(152):. PubMed ID: 31285289
[TBL] [Abstract][Full Text] [Related]
9. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.
Fodor AA; Klem ER; Gilpin DF; Elborn JS; Boucher RC; Tunney MM; Wolfgang MC
PLoS One; 2012; 7(9):e45001. PubMed ID: 23049765
[TBL] [Abstract][Full Text] [Related]
10. The polymicrobial nature of airway infections in cystic fibrosis: Cangene Gold Medal Lecture.
Sibley CD; Surette MG
Can J Microbiol; 2011 Feb; 57(2):69-77. PubMed ID: 21326348
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis.
Sherrard LJ; Tunney MM; Elborn JS
Lancet; 2014 Aug; 384(9944):703-13. PubMed ID: 25152272
[TBL] [Abstract][Full Text] [Related]
12. The cystic fibrosis lung microbiome.
Surette MG
Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409
[TBL] [Abstract][Full Text] [Related]
13. The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis.
Sibley CD; Parkins MD; Rabin HR; Surette MG
Curr Opin Investig Drugs; 2009 Aug; 10(8):787-94. PubMed ID: 19649923
[TBL] [Abstract][Full Text] [Related]
14. Lung function and microbiota diversity in cystic fibrosis.
Cuthbertson L; Walker AW; Oliver AE; Rogers GB; Rivett DW; Hampton TH; Ashare A; Elborn JS; De Soyza A; Carroll MP; Hoffman LR; Lanyon C; Moskowitz SM; O'Toole GA; Parkhill J; Planet PJ; Teneback CC; Tunney MM; Zuckerman JB; Bruce KD; van der Gast CJ
Microbiome; 2020 Apr; 8(1):45. PubMed ID: 32238195
[TBL] [Abstract][Full Text] [Related]
15. Three clinically distinct chronic pediatric airway infections share a common core microbiota.
van der Gast CJ; Cuthbertson L; Rogers GB; Pope C; Marsh RL; Redding GJ; Bruce KD; Chang AB; Hoffman LR
Ann Am Thorac Soc; 2014 Sep; 11(7):1039-48. PubMed ID: 24597615
[TBL] [Abstract][Full Text] [Related]
16. The microbiome and emerging pathogens in cystic fibrosis and non-cystic fibrosis bronchiectasis.
Green H; Jones AM
Semin Respir Crit Care Med; 2015 Apr; 36(2):225-35. PubMed ID: 25826590
[TBL] [Abstract][Full Text] [Related]
17. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R
Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960
[TBL] [Abstract][Full Text] [Related]
18. The future of antimicrobial therapy in the era of antibiotic resistance in cystic fibrosis pulmonary infection.
McCaughey G; Gilpin D; Elborn J; Tunney MM
Expert Rev Respir Med; 2013 Aug; 7(4):385-96. PubMed ID: 23964628
[TBL] [Abstract][Full Text] [Related]
19. Development of the respiratory tract microbiota in cystic fibrosis.
de Koff EM; de Winter – de Groot KM; Bogaert D
Curr Opin Pulm Med; 2016 Nov; 22(6):623-8. PubMed ID: 27583669
[TBL] [Abstract][Full Text] [Related]
20. The Microbiome in Cystic Fibrosis.
Huang YJ; LiPuma JJ
Clin Chest Med; 2016 Mar; 37(1):59-67. PubMed ID: 26857768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
